Hassabis Says AI Could Design Hundreds of New Drugs Simultaneously Within Decade
AI-summarised brief · reviewed before publication
Demis Hassabis, CEO of Google DeepMind, has predicted that artificial intelligence will enable the simultaneous design of hundreds of new drugs within the next five to 10 years. This is made possible by the work of Isomorphic Labs, a company spun off by Google DeepMind two to three years ago, which aims to accelerate drug development by tenfold. Hassabis also forecasted significant advancements in physical AI robotics, including automated research labs and household chores.
💡 Why It Matters
- · Hassabis' prediction of AI-designed drugs could revolutionize the pharmaceutical industry, potentially saving countless lives and reducing the time and cost associated with drug development.